Literature DB >> 2224281

Ciprofloxacin and myasthenia gravis.

C J Mumford1, L Ginsberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2224281      PMCID： PMC1663942          DOI： 10.1136/bmj.301.6755.818-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Possible exacerbation of myasthenia gravis by ciprofloxacin.

Authors:  B Moore; M Safani; J Keesey
Journal:  Lancet       Date:  1988-04-16       Impact factor: 79.321
  1 in total
  5 in total

1.  Myasthenic crisis.

Authors:  Linda C Wendell; Joshua M Levine
Journal:  Neurohospitalist       Date:  2011-01

2.  Probable exacerbation of myasthenia gravis by ofloxacin.

Authors:  E Azevedo; J A Ribeiro; J Polónia; C Pontes
Journal:  J Neurol       Date:  1993-09       Impact factor: 4.849

3.  Worsening of myasthenia gravis on treatment with imipenem/cilastatin.

Authors:  J O'Riordan; M Javed; C Doherty; M Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

Review 4.  Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

Authors:  S Christopher Jones; Alfred Sorbello; Robert M Boucher
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606

Review 5.  Quinolones: review of psychiatric and neurological adverse reactions.

Authors:  Ana M Tomé; Augusto Filipe
Journal:  Drug Saf       Date:  2011-06-01       Impact factor: 5.606
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.